Title(s): 
RTOG 0848. A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma
Investigator(s): Mitchel Fromm, MD
Contact Information: McDowell Cancer Research at 330.344.6348 

Title(s): 
CTSU S1505. A Randomized Phase II Study of Perioperative mFOLFIRINOX versus Gemcitabine/nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma
Investigator(s): Esther Rehmus, MD
Contact Information: McDowell Cancer Research at 330.344.6348